Products

Pliance

We keep good businesses from making bad headlines.

pliance.io Legal & Compliance / Compliance Automation

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
Siam Choudhury
No social account linked
Launched
8y ago
2018-02-24 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Feb 24, 2018 · 8y agoWebsite

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
GetLatka9 team membersFunding $500K
2026-10-29Source

Pliance is a Stockholm-based API-first compliance platform founded in 2018 that helps regulated financial institutions automate anti-money laundering screening, sanctions checks, and know-your-customer processes.

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2018-02-24

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Public pricing: PaidRaw source text; structured plans are extracted after website capture.

Pages & changes

Tracked since 2026-08-10

Key pages

Weekly snapshots
www.verified.io/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Pliance get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Pliance and what platforms does it support?
Pliance is catalogued under Compliance Automation: We keep good businesses from making bad headlines. Supported platforms: API.

Related products in this category

Legal & Compliance / Compliance Automation

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.